Sciomics: Enabling precision medicine -

  • Home
  • Protein & PTM analysis
    • scioDiscover
      Protein Expression Analysis
      • Protein Profiling
      • Protein Biomarker Discovery
      • Drug Target Discovery
      • Array content
      • Quality Assurance
      • scioDiscover - Features and Advantages
    • scioPhospho
      Phosphorylation + Protein Profiling
    • scioUbi
      Protein + ubiquitination profiling
      • scioUbi case study
    • scioCD
      cell surface marker + cytokine profiling
    • scioCyto
      Cytokine profiling
  • What our customers say
  • About us
    • Register for our newsletter
    • What our customers say
    • Scientific articles
    • Press releases
    • Your career at Sciomics
    • Our Partners & Networks
    • Contact us
      • test

News

Corona | Sciomics is fully operational

| 23 March 2020 | Through early preventive actions Sciomics is fully operational to address your protein profiling and biomarker projects. Thanks to our core laboratory team which is doing a fantastic job, while most of our employees are collaborating with you from home.

Stay heatlthy in these challenging times ! 
> more information

New article | Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer

| Jan 2019 | In the article, scientists at Tel Aviv University used our scioDiscover platform to analyse tumor-associated eosinophils in colorectal cancer. The full article is published in Cancer Immunology Research.

 

New article | Protection from ischemia reperfusion injury-induced inflammation and fibrosis in C5aR2-deficient mice

| June 2018 | Complement component 5a receptor 2 (C5AR2) deficient mice are protected from inflammation and fibrosis in response to ischemia reperfusion injury. Our scioPhospho platform supported scientists at the Medical School Hannover to elucidate the underlying mechanism. The data were recently published in Kidney International.

 

New article | Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells

| January 2018 | A scioDiscover protein microarray study contributed to an article in Cell Reports. In this study Gerard Ruiz-Babot et al. analysed a donor specific reprogramming of cells.

Customer testimonial Leonardo Guasti, PhD (senior author):

This has undoubtedly opened new avenues in our research. We have found the Sciomics team to be extremely helpful and efficient during the whole process, from advising the best strategy to the final interpretation of results.

> More testimonials

A glas full of hope | Ein Glas Hoffnung

| January 2018 | Article on the StartUp Sciomics and our antibody microarray platform by our partner SCHOTT nexterion.

> English version "A glass full of hope"

> Deutsche Version "Ein Glas Hoffnung"

Tweets

  • 12 days ago

    RT @car_endo: BioEndoCar @car_endo consortium is entering 2021 with optimism, getting closer to the aim of developing new #diagnostic and…

  • 45 days ago

    RT @MCDS_Therapy: UPDATE: We’re now in the dosing stage of the trial! This stage will prove if the drug #Carbamazepine is an effective &…

  • 46 days ago

    Great review „Extracellular vesicles and oncogenic signaling“ by @_A_Schubert and @Michael_Boutros @Boutroslab https://t.co/prUUaKHGRV

  • 51 days ago

    RT @BioValleyFrance: #LIVE #BVFevent I 😎 It’s time to be in the show for our pitchers: welcome to the short presentation session! 👂 Let’s l…

  • 53 days ago

    Nice surprise this morning in Heidelberg ! #wintertime #snowIsFun #NewTeamMember https://t.co/NHrWde0Xg8

Newsletter

Subscribe to our newsletter to keep updated on our product and service portfolio.

Subscribe

Contact

  This email address is being protected from spambots. You need JavaScript enabled to view it.
  +49 6221 4294830

 Contact us

BMBF-funding

Sponsored by the Federal Ministry of Education and Research (BmBF), GermanyInnovative through Research

Legal

Copyright © 2013-2018 Sciomics GmbH, All rights reserved.

Imprint / Impressum     Data Privacy Policy / Datenschutzerklärung

BACK_TO_TOP
  • Home
  • Protein & PTM analysis
    • scioDiscover
      Protein Expression Analysis
      • Protein Profiling
      • Protein Biomarker Discovery
      • Drug Target Discovery
      • Array content
      • Quality Assurance
      • scioDiscover - Features and Advantages
    • scioPhospho
      Phosphorylation + Protein Profiling
    • scioUbi
      Protein + ubiquitination profiling
      • scioUbi case study
    • scioCD
      cell surface marker + cytokine profiling
    • scioCyto
      Cytokine profiling
  • What our customers say
  • About us
    • Register for our newsletter
    • What our customers say
    • Scientific articles
    • Press releases
    • Your career at Sciomics
    • Our Partners & Networks
    • Contact us
      • test